[An assessment of the management of spasticity in Spain: the 5E Study].
CONCLUSIONS: Most of the patients have post-stroke spasticity. Moreover, botulinum A toxin was the most commonly treatment applied to patients with spasticity. The results demonstrate that the management of spasticity varies significantly across the different centers participating in the study.
PMID: 27658359 [PubMed - in process]
Source: Revista de Neurologia - Category: Neurology Authors: Garreta-Figuera R, Torrequebrada-Gimenez A, En Representacion Del Grupo de Estudio 5e ER Tags: Rev Neurol Source Type: research
More News: Epidemiology | Health | Hospital Management | Neurology | Pain | Pain Management | Physiotherapy | Rehabilitation | Stroke | Study